Literature DB >> 10561791

Persistent atrial standstill in a cat.

B J Gavaghan1, M D Kittleson, D McAloose.   

Abstract

A domestic shorthaired cat was presented with a 1-month history of cardiomegaly and recurrent chylothorax. The heart rate was 130 beats/min and no P waves were present on a surface electrocardiogram. Thoracic radiographs and an echocardiogram demonstrated severe biatrial dilatation, pleural effusion and restrictive pleural disease. Permanent atrial standstill was suspected. Pleurocentesis was performed and therapy was started with enalapril, frusemide and aspirin. Intracardiac electrograms revealed no atrial activity, and atrial pacing failed to elicit atrial or ventricular depolarisations. The patient was euthanased. Necropsy showed severe atrial wall thinning with marked cardiocyte loss. Persistent atrial standstill is a rare disease in the cat. Clinical signs may have been due to loss of atrial function, ventricular diastolic dysfunction, bradycardia, neurohormonal activation and reduced atrial natriuretic peptide plasma concentrations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10561791     DOI: 10.1111/j.1751-0813.1999.tb13192.x

Source DB:  PubMed          Journal:  Aust Vet J        ISSN: 0005-0423            Impact factor:   1.281


  4 in total

1.  Permanent transvenous pacemaker implantation in an Ibizan hound cross with persistent atrial standstill.

Authors:  Kevin MacAulay
Journal:  Can Vet J       Date:  2002-10       Impact factor: 1.008

2.  Atrioventricular muscular dystrophy in a 5-month-old English springer spaniel.

Authors:  Serene R Lai
Journal:  Can Vet J       Date:  2009-12       Impact factor: 1.008

Review 3.  Indications for permanent pacing in dogs and cats.

Authors:  R A Santilli; F Giacomazzi; D M Porteiro Vázquez; M Perego
Journal:  J Vet Cardiol       Date:  2019-01-29       Impact factor: 1.701

4.  The Feline Cardiomyopathies: 1. General concepts.

Authors:  Mark D Kittleson; Etienne Côté
Journal:  J Feline Med Surg       Date:  2021-11       Impact factor: 2.015

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.